Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies
Background: Rigorous assessment of antibody developability is crucial for optimizing lead candidates before progressing to clinical studies. Recent advances in predictive tools for protein structures, surface properties, stability, and immunogenicity have streamlined the development of new biologics...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2024-12-01
|
| Col·lecció: | Antibodies |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2073-4468/13/4/104 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|